Sanofi

Market Cap (₹ Cr.)

₹14,816

52 Week High

10,524.95

Book Value

₹441

52 Week Low

5,892.80

PE Ratio

30.16

PB Ratio

21.64

PE for Sector

50.84

PB for Sector

84.38

ROE

59.39 %

ROCE

79.66 %

Dividend Yield

2.60 %

EPS

₹213.31

Industry

Pharmaceuticals

Sector

Pharmaceuticals - Multinational

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Growth Rate

Revenue Growth

-

Net Income Growth

-

Cash Flow Change

-97.69 %

ROE

-

ROCE

-

EBITDA Margin (Avg.)

-

Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024
Revenue	524	560	595	649	582	631	653	620	569	629	688	689	640	704	770	747	740	771	802	851	814	741	702	744	751	806	1,258	704	850	715	703	706	780	572	726	706	579	504
Expenses	406	428	444	456	427	470	492	496	451	485	484	536	483	519	557	589	564	590	643	668	658	533	495	553	536	542	556	561	513	538	510	505	507	393	506	507	400	367
EBITDA	118	131	151	193	156	161	161	124	117	144	205	153	157	185	214	157	177	181	159	183	156	208	207	191	216	264	703	144	337	177	193	201	274	179	220	199	179	137
Operating Profit %	12 %	17 %	20 %	13 %	18 %	19 %	18 %	12 %	12 %	13 %	23 %	15 %	22 %	24 %	25 %	19 %	21 %	21 %	17 %	19 %	16 %	25 %	28 %	23 %	26 %	31 %	26 %	18 %	28 %	23 %	26 %	25 %	31 %	24 %	29 %	27 %	22 %	21 %
Depreciation	26	28	29	30	27	27	27	38	25	26	26	26	25	25	26	26	26	26	26	22	21	21	21	20	20	21	14	11	11	11	10	10	10	9	10	10	9	9
Interest	0	0	0	0	0	1	0	1	0	0	0	1	0	0	0	1	0	0	0	0	1	1	0	0	0	1	1	0	0	0	1	0	0	1	0	0	0	0
Profit Before Tax	92	103	122	164	128	133	134	85	92	118	179	126	132	160	188	131	151	155	133	161	135	187	186	170	195	243	688	132	326	166	182	190	264	169	210	189	169	127
Tax	28	39	50	43	46	50	58	39	38	41	65	42	50	63	71	56	59	63	33	72	54	57	54	47	54	68	171	43	83	46	53	63	74	47	59	50	40	27
Net Profit	65	64	73	120	83	86	83	53	60	74	116	76	83	100	119	79	93	97	127	97	85	136	133	123	146	178	530	90	238	120	131	131	190	123	152	138	137	103
EPS in ₹	28.04	27.86	31.52	52.09	35.91	37.43	36.04	22.89	26.09	32.04	50.57	33.05	35.87	43.30	51.83	34.48	40.34	42.29	54.96	42.26	37.08	59.18	57.71	53.41	63.35	77.42	230.04	39.25	103.51	52.28	56.84	56.84	82.67	53.37	66.08	59.79	59.31	44.90

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023
Total Assets	2,405	2,541	2,778	2,984	3,244	2,919	3,061	2,072	1,715
Fixed Assets	877	817	769	733	499	464	334	306	315
Current Assets	1,244	1,575	1,444	1,592	2,129	1,833	2,138	1,610	1,246
Capital Work in Progress	22	34	30	21	17	10	13	24	16
Investments	0	0	0	0	0	0	0	0	2
Other Assets	1,505	1,690	1,978	2,230	2,728	2,444	2,714	1,743	1,382
Total Liabilities	778	658	751	765	802	800	835	796	700
Current Liabilities	617	502	602	624	703	687	750	741	651
Non Current Liabilities	161	156	150	141	99	113	86	55	48
Total Equity	1,627	1,883	2,026	2,219	2,442	2,119	2,226	1,276	1,016
Reserve & Surplus	1,604	1,860	2,003	2,196	2,419	2,096	2,203	1,253	993
Share Capital	23	23	23	23	23	23	23	23	23

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023
Net Cash Flow	102	-13	168	104	295	78	341	-533	-612
Investing Activities	36	-155	-79	-73	66	276	631	651	36
Operating Activities	213	322	435	374	412	611	559	399	231
Financing Activities	-147	-180	-188	-197	-183	-810	-849	-1,583	-878

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Promoter	60.40 %	60.40 %	60.40 %	60.40 %	60.40 %	60.40 %	60.40 %	60.40 %	60.40 %	60.40 %	60.40 %	60.40 %	60.40 %	60.40 %	60.40 %
FIIs	11.54 %	10.87 %	10.34 %	9.22 %	8.99 %	8.71 %	8.26 %	6.99 %	6.71 %	6.72 %	6.80 %	6.31 %	6.11 %	5.81 %	5.78 %
DIIs	17.17 %	17.41 %	17.67 %	19.05 %	18.65 %	18.60 %	18.28 %	19.21 %	19.47 %	19.66 %	21.69 %	22.71 %	23.08 %	22.79 %	22.82 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	10.89 %	11.33 %	11.59 %	11.33 %	11.97 %	12.30 %	13.07 %	13.40 %	13.43 %	13.22 %	11.11 %	10.58 %	10.41 %	11.00 %	11.00 %

Show % Change

Dividend History

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Abbott	28,473.05	60,565.16	48.88	6,097.18	10.80	1,201	13.01	46.29
GlaxoSmithKline Pharmaceuticals	2,629.65	44,549.55	57.83	3,576.30	6.68	590	16.09	43.85
Pfizer	5,196.40	23,782.64	39.46	2,373.68	-6.02	551	6.30	31.09
AstraZeneca Pharma	7,340.00	18,466.38	140.96	1,330.33	29.27	162	-121.89	50.00
Sanofi	6,428.80	14,815.54	30.16	2,916.40	-	603	-16.03	36.04
Sanofi Consumer Healthcare	4,720.05	10,901.66	-	0.00	-	0	-69.11	42.56
Procter & Gamble Health	5,012.95	8,298.17	38.56	1,248.01	10.68	229	-43.73	37.16